See more here:
UNITY Biotechnology Announces Appointment of Alicia Tozier as Chief Strategy Officer
Category Archives: Global News Feed
Arcutis to Host ZORYVE® (Roflumilast) Cream 0.15% FDA Approval Call With KOL
SciSparc: MitoCareX Confirms Potential Significant Role of its Drug Target in Non-Small Cell Lung Cancer
Here is the original post:
SciSparc: MitoCareX Confirms Potential Significant Role of its Drug Target in Non-Small Cell Lung Cancer
Catalyst Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 7, 2024
HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200
The rest is here:
HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200
Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer
View original post here:
Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer
Aligos Therapeutics Announces Clinical Collaboration with Xiamen Amoytop Biotech Co., Ltd.
Aetna Policy Update Expands TMS Availability for Adolescents With Depression
See the original post:
Aetna Policy Update Expands TMS Availability for Adolescents With Depression
Windtree Therapeutics Announces Closing of Financing Through a Private Placement of Series C Preferred Stock
Clearside Biomedical Opens Registration for Suprachoroidal Delivery KOL Webinar to Be Held on Wednesday, July 24, 2024 at 8:00 am ET
TELA Bio to Announce Second Quarter 2024 Financial Results
T2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024
View original post here:
T2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024
Sanofi: Information concerning the total number of voting rights and shares – June 2024
Cronos Group Inc. Announces Results of Reconvened 2024 Annual Meeting of Shareholders
TransCode Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
See the original post:
TransCode Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
TransCode Therapeutics, Inc. Announces Pricing of Public Offering
Read this article:
TransCode Therapeutics, Inc. Announces Pricing of Public Offering
Rakovina Therapeutics Provides Update on Previously Announced Private Placement
Revolution Medicines Announces Publication Demonstrating Robust Anti-Tumor Activity of RAS(ON) Inhibitors in Preclinical Models of Refractory…
Oxurion provides clarification on the agenda of the extraordinary general shareholders’ meeting to be held on 24 July 2024
Nurix Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
See the original post here:
Nurix Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Provides a Corporate Update